Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers

NCT: NCT07862335 · NOT_YET_RECRUITING

NCT IDNCT07862335

StatusNOT_YET_RECRUITING

SponsorTiger Biosciences, LLC. (INDUSTRY)

First posted2026-10-07

Last updated2026-10-07

Brief Summary

To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic lower extremity wounds.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑